2018
DOI: 10.1111/jocs.13795
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac surgery for Chagas disease

Abstract: Although Chagas disease is a rare entity in North America, it is associated with significant cardiac morbidity. It is estimated that 20-30% of those who are infected will eventually develop cardiovascular disease secondary to Chagas disease. We review the literature and share our experience on the surgical management of this challenging patient population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 39 publications
0
4
0
1
Order By: Relevance
“…Survival per year has been estimated at 71% and at ten years at 46% post-transplant. However, there is a risk of disease reactivation secondary to post-transplant immunosuppression, although the evidence indicates that this could be treated with antimicrobial therapy as described above [159,160].…”
Section: Surgical Treatment 721 Heart Transplantmentioning
confidence: 99%
See 1 more Smart Citation
“…Survival per year has been estimated at 71% and at ten years at 46% post-transplant. However, there is a risk of disease reactivation secondary to post-transplant immunosuppression, although the evidence indicates that this could be treated with antimicrobial therapy as described above [159,160].…”
Section: Surgical Treatment 721 Heart Transplantmentioning
confidence: 99%
“…There is a 70% rate of parasitic recurrence within the first year after heart transplantation, with a 10% mortality rate in chagasic recipients [162]. Some studies show that a reduced immunosuppressive regimen does not increase allograft rejection in patients and is associated with lower rates of CD reactivation; studies have been conducted where azathioprine/cyclosporine combination causes less reactivation compared to mycophenolate [160]. Currently, infection and rejection are the leading causes of death among CD heart transplant recipients, occurring in 21% and 10-14% of patients, respectively [161].…”
Section: Surgical Treatment 721 Heart Transplantmentioning
confidence: 99%
“…An estimated 8 million people are infected with T. cruzi worldwide, with most infections occurring in South and Central America [159]. Operation may be indicated in the chronic phase, which can affect the gastrointestinal tract causing megacolon and mega-esophagus (10% of infected patients) or the heart, resulting in dilated cardiomyopathy (30%) [160][161][162].…”
Section: Chagas Diseasementioning
confidence: 99%
“…Серед кардіальних причин розвитку аневризм лівого шлуночка (АЛШ) окрім трансмурального інфаркту міокарда виявляють фістули коронарних артерій, інтрамуральний хід коронарних артерій, гі-пертрофічну кардіоміопатію, міокардит, аритмогенну кардіоміопатію правого шлуночка [1,2,3]. У літературі представлено поодинокі випадки виникнення АЛШ на тлі системних захворювань: інфекційного генезу (хвороба Чагаса, хвороба Бехчета, туберкульоз), сполучної тканини (системний червоний вовчак, саркоїдоз), хвороб накопичення глікогену, синдрому гіперімуноглобуліну Е, а також формування АЛШ унаслідок травми грудної клітки [1,[4][5][6][7][8][9][10][11][12][13][14][15][16][17][18]. АЛШ у військовослужбовців є результатом несвоєчасної реваскуляризації інфаркт-залежної артерії [18], вогнепального поранення серця [19], травми грудної клітки [2,20].…”
unclassified